Medical cannabis for treating various symptoms in Switzerland

Health Technology Assessment (HTA) is designed to assess the efficacy, safety, cost-effectiveness and budgetary impact of therapy with cannabis as compared with placebo, no therapy or standard of care in patients with various symptoms (pain, spasticity, vomiting and nausea in cancer patients, unintended weight loss).

Last modification 30.04.2021

Top of page

Contact

Federal Office of Public Health FOPH
Health insurance benefits Division
Health Technology Assessment Section
Schwarzenburgstrasse 157
3003 Bern
Switzerland
Tel. +41 58 469 17 33
E-mail

Print contact

https://www.bag.admin.ch/content/bag/en/home/versicherungen/krankenversicherung/krankenversicherung-leistungen-tarife/hta/hta-projekte/medizinalcannabis.html